AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 148 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $459,000 | +1175.0% | 638,600 | +3935.9% | 0.01% | +1000.0% |
| Q4 2021 | $36,000 | -83.4% | 15,823 | -79.0% | 0.00% | -83.3% |
| Q3 2021 | $217,000 | +13.0% | 75,240 | +48.2% | 0.01% | 0.0% |
| Q2 2021 | $192,000 | +65.5% | 50,772 | +48.0% | 0.01% | +50.0% |
| Q1 2021 | $116,000 | +114.8% | 34,302 | +77.4% | 0.00% | +100.0% |
| Q4 2020 | $54,000 | +3.8% | 19,332 | -6.2% | 0.00% | -33.3% |
| Q3 2020 | $52,000 | -81.3% | 20,620 | -71.0% | 0.00% | -88.0% |
| Q3 2019 | $278,000 | -67.4% | 71,000 | -31.7% | 0.02% | -69.9% |
| Q1 2019 | $852,000 | +134.1% | 104,000 | +57.9% | 0.08% | +56.6% |
| Q4 2018 | $364,000 | – | 65,852 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |